Introduction Attention-deficit/hyperactivity disorder (ADHD) is a major public health issue.
Pharmacological treatments play an important role in the multimodal treatment of ADHD …

Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders of children and adolescents, with a significant impact on …

The aim of this study is to gather evidence of head-to-head double-blind randomized-
controlled trials on the efficacy and safety of available treatments for attention deficit …

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used …

Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

The evidence base from empirical studies is one of the elements, along with patients'
preference and consideration of particular clinical state and circumstances, that should be …

Background Attention deficit hyperactivity disorder (ADHD) is a chronic behavioural disorder
that affects 5–8% of children. It is characterized by age‐inappropriate levels of inattention …

Purpose To systematically identify and review the currently available evidence on the long-
term outcomes of recommended attention-deficit hyperactivity disorder (ADHD) interventions …

Objective: Systematically review and synthesize the clinical evidence of treatments for
attention deficit hyperactivity disorder (ADHD) by indirectly comparing established …

Introduction It is unclear how pharmacological and non-pharmacological interventions
compare with each other in terms of efficacy and tolerability for core symptoms and …